메뉴 건너뛰기




Volumn 17, Issue SUPPL. 1, 2002, Pages

Pediatric partial and generalized seizures

Author keywords

[No Author keywords available]

Indexed keywords

ACETAZOLAMIDE; ANTICONVULSIVE AGENT; BENZODIAZEPINE DERIVATIVE; CARBAMAZEPINE; CLONAZEPAM; ETHOSUXIMIDE; ETIRACETAM; FELBAMATE; FOSPHENYTOIN SODIUM; GABAPENTIN; LAMOTRIGINE; OXCARBAZEPINE; PHENOBARBITAL; PHENYTOIN; PLACEBO; TOPIRAMATE; VALPROIC ACID; ZONISAMIDE;

EID: 0036236738     PISSN: 08830738     EISSN: None     Source Type: Journal    
DOI: 10.1177/08830738020170010901     Document Type: Article
Times cited : (7)

References (31)
  • 5
    • 0033541097 scopus 로고    scopus 로고
    • Oxcarbazepine: A double blind, randomized, placebo-control, monotherapy trial in patients with epilepsy after presurgical evaluation of refractory partial seizures
    • (1999) Neurology , vol.52 , pp. 732-737
    • Schachter, S.C.1    Vazquez, B.2    Fisher, R.S.3
  • 9
    • 0000355269 scopus 로고    scopus 로고
    • Gabapentin (Neurontin) monotherapy in children with benign childhood epilepsy with centrotemporal spikes (BECTS): A 36-week, double-blind, placebo-controlled study, abstract
    • (1998) Epilepsia , vol.39 , Issue.SUPPL. 6
    • Bourgeois, B.1    Brown, L.W.2    Pellock, J.M.3
  • 10
    • 0034642333 scopus 로고    scopus 로고
    • Expanding first-line therapy options for children with partial seizures
    • (2000) Neurology , vol.55 , Issue.SUPPL. 3
    • Glauser, T.A.1
  • 19
    • 0001066124 scopus 로고    scopus 로고
    • Topiramate monotherapy: Randomized controlled trial in patients with recently diagnosed localization-related epilepsy, abstract
    • (1999) Neurology , vol.52 , Issue.SUPPL. 2
    • Gilliam, F.G.1    Reife, R.2    Wu, S.-C.3
  • 27
    • 0001262685 scopus 로고    scopus 로고
    • Topiramate monotherapy for children with absence seizures: Results from an open-label pilot study
    • (1998) Epilepsia , vol.39 , Issue.SUPPL. 6 , pp. 164
    • Cross, J.H.1
  • 28
    • 2142845272 scopus 로고    scopus 로고
    • Code of Federal Regulations. 21 CFR section 201.57. Available at Accessed Dec 26
    • (2001)
  • 29
    • 2142672413 scopus 로고    scopus 로고
    • Section 505A of the Food and Drug Administration Modernization Act; The Pediatric Exclusivity Provision. Available at: Accessed Dec 26
    • (2001)
  • 30
    • 2142840235 scopus 로고    scopus 로고
    • The Pediatric Exclusivity Provision January 2001 Report, Status Report to Congress. Department of Health and Human Services, US Food and Drug Administration. Available at: Accessed Dec 26
    • (2001)
  • 31
    • 2142785967 scopus 로고    scopus 로고
    • Regulations Requiring Manufacturers to Assess the Safety and Effectiveness of New Drugs and Biological Products in Pediatric Patients: Final Rule
    • Code of Federal Regulations Part 201,312,314,601. Available at: cgi?title=200121. Accessed Dec 26
    • (2001)


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.